XpresSpa Group Signs Contract with HyperPointe™ for Airport-based COVID-19 Screening and Testing
June 05 2020 - 8:30AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has
partnered with HyperPointe in connection with, XpresCheck, its
newly formed business unit that will provide COVID-19 screening and
testing in U.S. airports.
Ezra T. Ernst, HyperPointe CEO, said, “We are
extremely proud and excited to be working with XpresCheck in
combatting this global pandemic and doing our part to help get the
country back to normal. Airports serve as the gateway to our
country, and ensuring their safety is a key step in getting us back
to business as usual.”
HyperPointe is providing a full range of support
that extends far beyond marketing, according to Mr. Ernst.
“We like to think of ourselves as co-pilots in
helping XpresCheck launch this exciting new initiative. Our
strategists have helped them design a workflow with the capacity to
test thousands of people each week with minimal disruption to the
workday. Our creatives have produced comprehensive promotional,
educational and digital solutions to facilitate a successful
rollout. In addition, our technology team is integrating the
XpresCheck workflow with AdvancedMD’s Practice Management and EHR
solution for online appointment scheduling, patient intake, lab
integration, medical billing and reporting analytics.”
In addition, the robust set of blind data
generated by the testing program can be used to inform COVID-19
surveillance programs and drive future measures that will help
ensure the safety of U.S. borders. Based on the development of the
partnership with HyperPointe, the Company has decided not to move
forward with any further engagements with Relevant Cost Containment
Healthcare® and Healthalytica, LLC.
XpresCheck has begun construction and intends to
start a pilot program at New York’s John F. Kennedy International
Airport Terminal 4 by the end of June, offering testing for airline
employees, contractors and workers, airport concessionaires and
their employees, TSA officers, and U.S. Customs and Border
Protection agents.
XpresCheck also plans to expand with locations
in additional airports to serve travelers as well as industry
personnel.
Doug Satzman, XpresSpa Group CEO, said, “We
believe we have a significant role to play in the fight against
COVID-19 given our airport relationships, infrastructure,
workforce, and strong desire to keep travelers and the entire
airport community safe. HyperPointe has been an indispensable
partner in that mission. Their expertise in the healthcare space
has helped us navigate the complexities of the industry, while
assisting us rapidly adjust to the ever-changing environment
brought on by this global pandemic.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a health and wellness
holding company. XpresSpa Group’s core asset, XpresSpa, is a
leading airport retailer of spa services and related health and
wellness products, with 51 locations in 25 airports globally.
XpresSpa offers services that are tailored specifically to the busy
travel customer. XpresSpa is committed to providing exceptional
customer experiences with its innovative premium spa services, as
well as luxury travel products and accessories. XpresSpa provides
almost one million services to customers per year at its locations
in the United States, Netherlands, and the United Arab Emirates. To
learn more about XpresSpa Group, visit: www.XpresSpaGroup.com. To
learn more about XpresSpa, visit www.XpresSpa.com.
About
HyperPointeTMHyperPointeTM is an independently owned,
full-service health and wellness marketing agency located in
Teaneck, NJ. Throughout its history of 30+ years, HyperPointeTM has
served as a valuable partner to a diverse array of global and
domestic health brands by building deep, personal connections to
the patients, caregivers, and healthcare providers they serve. To
learn more, visit www.Hyperpointe.com.
Forward-Looking StatementsThis
press release may contain "forward-looking" statements within the
meaning of Section 27A of the Securities Act of 1933, and Section
21E of the Securities Exchange Act of 1934. These include
statements preceded by, followed by or that otherwise include the
words "believes," "expects," “plans,” "anticipates," "estimates,"
"projects," "intends," "should," "seeks," "future," "continue," or
the negative of such terms, or other comparable terminology.
Forward-looking statements relating to expectations about future
results or events are based upon information available to XpresSpa
Group as of today's date and are not guarantees of the future
performance of the company, and actual results may vary materially
from the results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Gross(203) 682-8253IR@xpresspagroup.com
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2024 to May 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From May 2023 to May 2024